SCHEMBL10703057

SCHEMBL10703057

C=C1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(OC(=O)CC)C(C)=O)[C@]2(C)C1=CC(=O)[C@@H]1C[C@@H]12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 8/20 0.54
▸ NR3C1 P04150 8/20 0.54
▸ AR P10275 7/20 0.54
▸ PGR P06401 7/20 0.54
▸ LMNA P02545 5/20 0.54
▸ ALDH1A1 P00352 3/20 0.54
▸ CHRM2 P08172 3/20 0.54
▸ CYP2C9 P11712 3/20 0.54
▸ MAPK1 P28482 3/20 0.54
▸ MAPT P10636 2/20 0.54
▸ TSHR P16473 1/20 0.54
▸ OPRM1 P35372 1/20 0.54
▸ PDE3A Q14432 2/20 0.42
▸ DRD1 P21728 1/20 0.42
▸ OPRK1 P41145 1/20 0.42
▸ SMN1; SMN2 Q16637 5/20 0.42
▸ NPSR1 Q6W5P4 4/20 0.42
▸ HIF1A Q16665 3/20 0.42
▸ PDE4D Q08499 2/20 0.42
▸ MEN1 O00255 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10705486 0.93 NR3C1 (0.53) CYP3A4NR3C1ARPGRLMNA
SCHEMBL10706225 0.92 NR3C1 (0.52) CYP3A4NR3C1ARPGRLMNA
SCHEMBL10703140 0.91 CYP3A4 (0.65) CYP3A4NR3C1ARPGRLMNA
SCHEMBL10704394 0.91 CYP3A4 (0.55) CYP3A4NR3C1ARPGRLMNA
SCHEMBL10703728 0.86 CYP3A4 (0.50) CYP3A4NR3C1ARPGRLMNA
SCHEMBL10707927 0.83 CYP3A4 (0.44) CYP3A4NR3C1ARPGRLMNA
SCHEMBL10703308 0.83 AR (0.54) CYP3A4NR3C1ARPGRLMNA
SCHEMBL10703144 0.82 NR3C1 (0.54) CYP3A4NR3C1ARPGRLMNA
SCHEMBL11798376 0.81 CYP3A4 (0.51) CYP3A4NR3C1ARPGRLMNA
SCHEMBL11798382 0.81 CYP3A4 (0.51) CYP3A4NR3C1ARPGRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0153270-B1 1-ALPHA, 2-ALPHA-METHYLENE-6-METHYLENE AND 6-ALPHA-METHYL PREGNENES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING AKTIENGESELLSCHAFT (DE) 1988-07-27 — — EP claimed
EP-0153270-A2 1-Alpha, 2-alpha-methylene-6-methylene and 6-alpha-methyl pregnenes, process for their preparation and pharmaceutical compositions containing them SCHERING AKTIENGESELLSCHAFT (DE) 1985-08-28 — — EP claimed
EP-0153270-B1 1-ALPHA, 2-ALPHA-METHYLENE-6-METHYLENE AND 6-ALPHA-METHYL PREGNENES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING AKTIENGESELLSCHAFT (DE) 1988-07-27 — — EP disclosed
US-4670427-A ANTIANDROGENS SCHERING AKTIENGESELLSCHAFT (DE) 1987-06-02 — — US disclosed
EP-0153270-A2 1-Alpha, 2-alpha-methylene-6-methylene and 6-alpha-methyl pregnenes, process for their preparation and pharmaceutical compositions containing them SCHERING AKTIENGESELLSCHAFT (DE) 1985-08-28 — — EP disclosed
Send feedback